FDA’s decision on Logic gives way to concerns over pending PMTAs

The recent decision by the US Food and Drug Administration (FDA) on Logic’s products has raised some concerns among experts on how the federal agency will address the pending premarket tobacco product applications (PMTAs), Juul and Njoy among them.

The FDA has recently authorised the marketing of Logic’s several tobacco-flavoured e-cigarettes under its brands Logic Power and Logic Pro, whilst it denied others from the same company owned by Japan Tobacco International (JTI). At the same time, the agency stated that the decisions on other vendors’ PMTAs would be coming soon, including perhaps the long-awaited verdict on Juul.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us